Ignite Creation Date:
2024-05-06 @ 10:34 AM
Last Modification Date:
2024-10-26 @ 12:32 PM
Study NCT ID:
NCT03294694
Status:
TERMINATED
Last Update Posted:
2022-03-31
First Post:
2017-09-19
Brief Title:
Ribociclib PDR001 in Breast Cancer and Ovarian Cancer
Sponsor:
Dana-Farber Cancer Institute
Organization:
Dana-Farber Cancer Institute
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Metastatic Hormone-Receptor-Positive HR Breast Cancer |
| HER2-Negative Breast Cancer |
| Metastatic Epithelial Ovarian Cancer |